Since low CARM1 expression is associated with increased GBM patient survival and has been previously reported to slow cell growth in LN229 cells [33], we hypothesized that depletion of CARM1 would also slow proliferation of Glioma stem-like cells. The gene discussed is CARM1; the disease is central nervous system cancer.